HB 1281: Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs
Latest action, March 13, 2026: Died in Health Care Facilities & Systems Subcommittee
Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies & from interfering with pharmacies' rights to contract with 340B entities; prohibits health insurance issuers, PBMs & other third-party payors, & agents, from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibits health insurers & HMOs from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain actions & penalties.
The bill’s record: its number and title, where it stands, its sponsors, every action in its legislature’s words, every version, the roll calls on it, and every change the site recorded, with LegiScan’s license.